Gilead Sciences stock nears its all-time high
Why Is Gilead Sciences, Inc. (GILD) Stock Surpassing 9.90% from Its 50-Day SMA?
Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $81.44 which represents a slight increase of $2.27 or 2.87% from the prior close of $79.17. The stock opened at $79.17 and touched a low of $78.
Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $902.07 today based on a ...
Gilead Sciences (GILD ... shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on this, we've crafted the Zacks Rank, a unique model that ...
Recap of the Week’s Most Important Stories: GILD Stock Soars on HIV Drug Data ... They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market ...
But we should not assume that Gilead Sciences’ stock price will not be affected by a steep bear market. Most likely it will decline as well – but maybe the decline is less steep and maybe the ...
Leerink Partners analyst Daina Graybosch has maintained their neutral stance on GILD stock, giving a Hold rating on September 12. “Daina ...
Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...
Yee notes that while Gilead's stock has not moved much over the last few years, it will likely take off as it moves forward with its new HIV prevention drug. "They have announced this week a ...
J.P. Morgan analyst Chris Schott has maintained their bullish stance on GILD stock, giving a Buy rating yesterday. Chris Schott has given his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback